Related Experiment Video
Updated: Jun 18, 2026

Amplitude-Integrated EEG in Infants at Risk of Hypoxic-Ischemic Encephalopathy: A Feasibility Study in Road and Air Transport in Western Australia
Published on: June 21, 2024
The national protocol for paediatric amplification in Australia
1Australian Hearing, Box Hill, Victoria, Australia. alison.king@hearing.com.au
Insights
This Australian protocol ensures optimal hearing aid fitting for children with hearing loss, including specialized care for auditory neuropathy spectrum disorder and cochlear implants. It utilizes advanced technology and evidence-based methods for effective audiological management.
Area of Science:
- Audiology
- Pediatric Hearing Healthcare
- Biomedical Engineering
Background:
- National audiological management for Australian children under 21 with hearing loss.
- Australian Hearing provides fully subsidised hearing aids, FM systems, and audiological management.
- Focus on comprehensive care for diverse hearing impairments, including auditory neuropathy spectrum disorder, mild/unilateral loss, and cochlear implantation.
Purpose of the Study:
- To detail the national protocol for selecting, fitting, verifying, and evaluating amplification devices for hearing-impaired children.
- To outline management strategies for specific pediatric hearing conditions.
- To ensure evidence-based audiological practices are consistently applied.
Main Methods:
- Utilisation of multi-channel hearing aids with advanced features (wide dynamic range compression, directional microphones, feedback cancellation).
- Application of the NAL-NL1 prescription procedure for hearing aid gain, frequency response, and maximum power output.
- Verification through real ear measurements and evaluation via speech perception tests and functional assessment questionnaires.
Main Results:
- Standardized protocol ensures consistent and effective amplification selection, fitting, and verification.
- Comprehensive management approach addresses a wide spectrum of pediatric hearing loss.
- Advanced hearing aid technology and evidence-based procedures are employed for optimal outcomes.
Conclusions:
- The national protocol provides a robust framework for pediatric audiological management in Australia.
- Effective amplification and management strategies improve outcomes for children with hearing loss.
- Ongoing evaluation ensures the protocol's continued relevance and efficacy.
Abstract:
This document describes the national protocol for the selection, fitting, verification, and evaluation of amplification for hearing-impaired children in Australia. It also outlines the approach to management of children who have auditory neuropathy spectrum disorder, children who have mild and unilateral hearing loss, and children who require cochlear implantation. Audiological management of all Australian citizens and permanent residents under twenty-one years of age who have a hearing loss is carried out by the national hearing service provider, Australian Hearing. It is funded by the Australian Government's Hearing Services Program to provide fully subsidised hearing aids, frequency modulated (FM) systems and ongoing audiological management. All hearing aids for children are multi-channel devices that offer wide dynamic range compression, directional microphone technology and feedback cancellation as well as access to multiple listening programs, telecoil and audio-input facilities. Hearing aid gain, frequency response and maximum power output are derived according to the NAL-NL1 prescription procedure and verified using real ear measurements. Amplification benefit is evaluated using a range of speech perception tests and functional assessment questionnaires.
More Related Videos
08:42A Familiarization Protocol Facilitates the Participation of Children with ASD in Electrophysiological Research
Published on: July 31, 2017
11:13Collection, Expansion, and Differentiation of Primary Human Nasal Epithelial Cell Models for Quantification of Cilia Beat Frequency
Published on: November 10, 2021
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
PCR